Fennec Pharmaceuticals (FENC) Receivables - Net (2022 - 2025)
Fennec Pharmaceuticals' Receivables - Net history spans 4 years, with the latest figure at $23.2 million for Q4 2025.
- For the quarter ending Q4 2025, Receivables - Net rose 80.23% year-over-year to $23.2 million, compared with a TTM value of $23.2 million through Dec 2025, up 80.23%, and an annual FY2025 reading of $23.2 million, up 80.23% over the prior year.
- Receivables - Net for Q4 2025 was $23.2 million at Fennec Pharmaceuticals, up from $19.3 million in the prior quarter.
- The five-year high for Receivables - Net was $23.2 million in Q4 2025, with the low at $1.5 million in Q4 2022.
- Average Receivables - Net over 4 years is $11.0 million, with a median of $12.3 million recorded in 2024.
- Year-over-year, Receivables - Net surged 510.46% in 2024 and then skyrocketed 42.15% in 2025.
- Tracing FENC's Receivables - Net over 4 years: stood at $1.5 million in 2022, then skyrocketed by 470.49% to $8.8 million in 2023, then soared by 46.18% to $12.9 million in 2024, then skyrocketed by 80.23% to $23.2 million in 2025.
- Per Business Quant, the three most recent readings for FENC's Receivables - Net are $23.2 million (Q4 2025), $19.3 million (Q3 2025), and $17.5 million (Q2 2025).